Introduction
  1. H.R. 676 was introduced originally by Representative Conyers. On March 7, 2018, Representative Ellison received unanimous consent to be considered the first sponsor.

    ← Return to text

Issue Brief
  1. The Stabenow bill does not include a provision to authorize the Secretary to negotiate lower drug prices; however, Senator Stabenow has co-sponsored other legislation that would do so.

    ← Return to text

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.